Literature DB >> 171328

Hidradenomata of the external auditory meatus. (Review of the literature and report of a pleomorphic adenoma).

A L Pahor, M D O'Hara.   

Abstract

A case of hidradenoma of the external auditory meatus ('ceruminoma') is presented, with a review of the literature. The tumour has the appearances of a pleomorphic adenoma and is devoid of a capsule. It is suggested that the term hidradenoma be used for tumours of the ceruminous glands and that they be classified histologically as (1) adenoma, (2) pleomorphic adenoma, (3) adenoid cystic carcinoma and (4) adenocarcinoma. This classification aids treatment and prognosis. Attention is drawn to the high incidence of malignancy in hidradenomata of the external auditory meatus. The treatment of choice for pleomorphic adenomata is wide surgical excision with an adequate margin of normal skin. If there is doubt regarding complete removal, or a recurrence develops, a wider surgical excision is necessitated.

Entities:  

Mesh:

Year:  1975        PMID: 171328     DOI: 10.1017/s0022215100080920

Source DB:  PubMed          Journal:  J Laryngol Otol        ISSN: 0022-2151            Impact factor:   1.469


  4 in total

1.  Ceruminous gland carcinomas: a clinicopathologic and immunophenotypic study of 17 cases.

Authors:  Nikhil Crain; Brenda L Nelson; E Leon Barnes; Lester D R Thompson
Journal:  Head Neck Pathol       Date:  2008-12-03

Review 2.  Pleomorphic adenoma presenting with conductive hearing loss in the ear canal: a case report and review of the literature.

Authors:  Ayako Maruyama; Takao Tokumaru; Ken Kitamura
Journal:  J Med Case Rep       Date:  2014-06-06

3.  A case of conservatively managed invasive ceruminoma and a review of the literature.

Authors:  T F C Saunders; P Monksfield
Journal:  Case Rep Otolaryngol       Date:  2014-07-22

Review 4.  Pleomorphic Adenoma of External Auditory Canal: Case Report of First Endoscopic Resection and Literature Review.

Authors:  Sven Beckmann; Matthias S Dettmer; Marco D Caversaccio; Roland Giger; Lukas Anschuetz
Journal:  Medicina (Kaunas)       Date:  2020-05-20       Impact factor: 2.430

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.